Neola Medical AB (OSTO:NEOLA) EV-to-EBIT : -12.62 (As of May. 17, 2024)

Neola Medical AB EV-to-EBIT Chart

Neola Medical AB Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial														-3.38	-6.63	-6.95	-4.01	-11.97

Competitive Comparison of Neola Medical AB's EV-to-EBIT

For the Medical Devices subindustry, Neola Medical AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neola Medical AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Neola Medical AB's EV-to-EBIT falls into.

Neola Medical AB EV-to-EBIT Calculation

Neola Medical AB's EV-to-EBIT for today is calculated as:

Neola Medical AB's current Enterprise Value is kr121.53 Mil.
Neola Medical AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neola Medical AB  (OSTO:NEOLA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Neola Medical AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Neola Medical AB's Enterprise Value for the quarter that ended in Dec. 2023 was kr115.21 Mil.
Neola Medical AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neola Medical AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Neola Medical AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Neola Medical AB (OSTO:NEOLA) Business Description